Markus Müschen, MD-PhD, is the Director of the Center of Molecular and Cellular Oncology, Arthur H. and Isabel Bunker Professor of Hematology, and Professor of Immunobiology at Yale University. He also serves as Chief of the Division of Basic Science of Yale Cancer Center. His research program focuses on signal transduction and metabolic pathways in lymphoid malignancies and how they can be intercepted for the treatment of drug-resistant leukemia and lymphoma.

Markus Müschen studied Medicine in Cologne, Germany and the Institut Pasteur in Paris, France. After his clinical training in hematology-oncology with Volker Diehl at the University of Cologne, he completed postdoctoral fellowships in immunology with Klaus Rajewsky and studied leukemia genetics with the late Janet D. Rowley at the University of Chicago.

Before coming to Yale, Markus Müschen’s laboratory was at the University of California San Francisco (UCSF) for seven years where he served as Program Leader of the Hematological Malignancies Program at the UCSF Comprehensive Cancer Center. Markus Müschen has been awarded an NCI Outstanding Investigator Award (R35) in 2016 and 2022. He is currently a Howard Hughes Medical Institute (HHMI) Faculty Scholar, an elected member of the American Society of Clinical Investigation. As Chief of the Basic Science Division at Yale Cancer Center, he serves as primary mentor for nine junior faculty and research group leaders.